Redefining the approach to age-related eye health issues and risk managementAccurately measuring over 4 million eyes since 2006, the QuantifEye® MPS II applies advanced technology and an intuitive interface for comfortable and accurate macular pigment optical density (MPOD) measurement.
MPOD measurement allows eye care professionals to assess a key age-related eye health risk factor, low macular pigment, as well as other visual performance challenges.
The QuantifEye® gives patients a score between 0 (low) and 1 (high) for their macular pigment density. Unfortunately, 78% of the population has suboptimal MPOD scores, but these scores can be improved through nutritional supplementation.
Healthy MPOD is important for three specific reasons:
QuantifEye Features and Benefits:
Primary benefits of MPOD measurement:
QuantifEye MPS II vs. Densitometer
|Points of Comparison||QuantifEye*||Densitometer**|
|Ability to store patient name and score in device for later viewing||Yes||No|
|Ability to electronically transfer patient MPOD results into EMR||Yes||No|
|Graph to assess MPOD measurement accuracy||Yes||No|
|Graph to determine if patient understood how to take the exam||Yes||No|
|Flicker sensitivity adjustment||Yes - Automatic||Yes - Manual|
|Ability to measure central and peripheral MPOD||Yes||Yes|
|Ability to estimate peripheral MPOD (time saver)||Yes||No|
|Number of purchase options||3||?|
|Time required to measure MPOD||2-3 minutes||7-10 minutes|
|Calibration requirements||Not necessary||Daily (5 minutes)|
“I was a very early adopter of QuantifEye MPOD measurement in my practice. I quickly realized that MPOD testing is a very valuable, if not critical, clinical tool for not only detecting low levels of macular pigment density, but identifying the population at risk for AMD and giving the clinician the ability to follow the progress of treatment plans”.
John Herman, OD, FAAO
"Our relationship with ZeaVision has been one of our best vendor partnerships. Their trainers installed the QuantifEye MPOD instrument and EyePromise supplements and provided exceptional training for our staff. Our patients, doctors, and staff are very enthusiastic about the new technology. The program was easy to implement, provides enhanced patient care, and is making our practice more profitable. Our monthly MPOD testing and supplement profit has averaged $4,000 since implementation."
Shelley Williams, OD
"The QuantifEye instrument and EyePromise supplements have enabled us to make a significant, measurable impact on our dry macular degeneration patients’ quality of vision, and has helped us identify those who may be at risk for macular degeneration. Measuring macular pigment is one of the most useful and important tests we perform. Hearing first hand from our patients how treating their low macular pigment has improved their quality of life is very rewarding."
Jay Burlingame, OD
Overland Park, KS
The QuantifEye® Program is trusted as the industry-standard turnkey program for measuring Macular Pigment Optical Density (MPOD) and nutraceutical vision support.
From doctors to athletes, professionals in every field rely on our products and industry-leading insights.
In addition to national eye health studies, we sponsor research with leading university science programs across the country. With research and testing behind the effectiveness of our products, you can be confident that your patients will see results with EyePromise.
As part of the EyePromise QuantifEye Program, you can try the QuantifEye MPS II in your practice for 60-days, risk-free. Additionally, the QuantifEye can be purchased or leased, and EyePromise offers several options and programs to suit all types of practices.
Your free trial includes: